deltatrials
Active Not Recruiting PHASE2 INTERVENTIONAL 1-arm NCT03179917

Pembrolizumab and Involved Site Radiation Therapy for Early Stage Relapsed or Primary Refractory Hodgkin Lymphoma

Sponsor: Memorial Sloan Kettering Cancer Center

Conditions Hodgkin Lymphoma
Interventions Involved Site Radiation Therapy Pembrolizumab
Updated 24 times since 2017 Last updated: May 6, 2025 Started: Jun 8, 2017 Primary completion: Jun 30, 2026 Completion: Jun 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Hodgkin Lymphoma, this trial is ongoing. The trial is conducted by Memorial Sloan Kettering Cancer Center and has accumulated 24 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jun 2017 – ~Jul 2017 · 30 days · monthly snapshot~Jul 2017 – ~Jun 2018 · 11 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~May 2019 · 10 months · monthly snapshot~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Nov 2019 · 5 months · monthly snapshot~Nov 2019 – ~Jan 2020 · 2 months · monthly snapshot~Jan 2020 – ~Jun 2020 · 5 months · monthly snapshot~Jun 2020 – ~Sep 2020 · 3 months · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~Sep 2022 · 9 months · monthly snapshot~Sep 2022 – ~Apr 2023 · 7 months · monthly snapshot~Apr 2023 – ~Jan 2024 · 9 months · monthly snapshot~Jan 2024 – ~Feb 2024 · 31 days · monthly snapshot~Feb 2024 – ~Mar 2024 · 29 days · monthly snapshot~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~Jan 2025 · 3 months · monthly snapshot~Jan 2025 – ~May 2025 · 4 months · monthly snapshot~May 2025 – ~Jun 2025 · 31 days · monthly snapshot~Jun 2025 – present · 15 months · monthly snapshot

Change History

24 versions recorded

  1. Jun 2025 — Present [monthly]

    Active Not Recruiting PHASE2

  2. May 2025 — Jun 2025 [monthly]

    Active Not Recruiting PHASE2

  3. Jan 2025 — May 2025 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  4. Oct 2024 — Jan 2025 [monthly]

    Recruiting PHASE2

  5. Sep 2024 — Oct 2024 [monthly]

    Recruiting PHASE2

▶ Show 19 earlier versions

  1. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

  2. Mar 2024 — Jul 2024 [monthly]

    Recruiting PHASE2

  3. Feb 2024 — Mar 2024 [monthly]

    Recruiting PHASE2

  4. Jan 2024 — Feb 2024 [monthly]

    Recruiting PHASE2

  5. Apr 2023 — Jan 2024 [monthly]

    Recruiting PHASE2

  6. Sep 2022 — Apr 2023 [monthly]

    Recruiting PHASE2

  7. Dec 2021 — Sep 2022 [monthly]

    Recruiting PHASE2

  8. Sep 2021 — Dec 2021 [monthly]

    Recruiting PHASE2

  9. Jan 2021 — Sep 2021 [monthly]

    Recruiting PHASE2

  10. Sep 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  11. Jun 2020 — Sep 2020 [monthly]

    Recruiting PHASE2

  12. Jan 2020 — Jun 2020 [monthly]

    Recruiting PHASE2

  13. Nov 2019 — Jan 2020 [monthly]

    Recruiting PHASE2

  14. Jun 2019 — Nov 2019 [monthly]

    Recruiting PHASE2

  15. May 2019 — Jun 2019 [monthly]

    Recruiting PHASE2

  16. Jul 2018 — May 2019 [monthly]

    Recruiting PHASE2

  17. Jun 2018 — Jul 2018 [monthly]

    Recruiting PHASE2

  18. Jul 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  19. Jun 2017 — Jul 2017 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Memorial Sloan Kettering Cancer Center
Data source: Memorial Sloan Kettering Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations